Profil
Nicholas Cross is the founder of Immunocore Holdings Plc, which was founded in 2008.
He is currently the Executive Chairman at Accession Therapeutics Limited.
Mr. Cross was formerly the Chairman at Oxford Asymmetry International Plc, Director at Avidex Ltd. from 2006 to 2008, and Non-Executive Director at Oxxon Therapeutics, Inc.
Aktiva positioner av Nicholas Cross
| Företag | Position | Start |
|---|---|---|
Accession Therapeutics Limited
Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics | Ordförande | - |
Tidigare kända positioner av Nicholas Cross
| Företag | Position | Slut |
|---|---|---|
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Direktör/Styrelseledamot | 2008-12-04 |
| IMMUNOCORE HOLDINGS PLC | Grundare | - |
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Ordförande | - |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Oxford Asymmetry International Plc
Oxford Asymmetry International Plc Chemicals: SpecialtyProcess Industries Specializes in the discovery and development of new drugs | Process Industries |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs for the treatment of cancer and autoimmune diseases | Health Technology |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures antigen-specific immunotherapy’s to treat patients | Health Technology |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Accession Therapeutics Limited
Accession Therapeutics Limited BiotechnologyHealth Technology Develops novel immuno-oncology therapeutics | Health Technology |
















